Quantcast
Home > Quotes > ZTS

Zoetis Inc. Class A Common Stock (ZTS) Quote & Summary Data

ZTS 
$88.92
*  
0.83
0.94%
Get ZTS Alerts
*Delayed - data as of Dec. 10, 2018  -  Find a broker to begin trading ZTS now
Exchange:NYSE
Industry: Health Care
Community Rating:
View:    ZTS After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

1 Year Target
100
Today's High / Low
$ 89.37 / $ 87.30
Share Volume
1,926,320
90 Day Avg. Daily Volume
2,312,646
Previous Close
$ 88.09
52 Week High / Low
$ 96.57 / $ 70.20
Market Cap
42,721,692,427
P/E Ratio
37.36
Forward P/E (1y)
28.32
Earnings Per Share (EPS)
$ 2.38
Annualized Dividend
$ .50
Ex Dividend Date
11/19/2018
Dividend Payment Date
12/3/2018
Current Yield
0.57 %
Beta
1.17

Intraday Chart

Shares Traded

Share Volume:
1,926,320
90 Day Avg. Daily Volume:
2,312,646

P/E Ratio

P/E Ratio:
37.36
Forward P/E (1y):
28.32
Earnings Per Share (EPS):
$ 2.38

Trading Range

The current last sale of $88.92 is 26.67% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 89.37 $ 96.57
 Low: $ 87.30 $ 70.20

ETFs with ZTS as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
8.47% VanEck Vectors Agribusiness ETF (MOO) -2.27 (-3.63%)
4.81% iShares U.S. Pharmaceutical ETF (IHE) -5.66 (-3.56%)
4.45% First Trust Nasdaq Pharmaceuticals ETF (FTXH) -0.86 (-3.94%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

Zoetis Inc. is a global leader in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. We have a diversified business, commercializing products across eight core species: cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals); and within five major product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals. For more than 60 years, we have been committed to enhancing the health of animals and bringing solutions to our customers who raise and care for them. We were incorporated in Delaware in July 2012 and prior to that the company was a business unit of Pfizer Inc. (Pfizer). The address of our principal executive offices is 10 Sylvan Way, Parsippany, New Jersey 07054.  ... More ...  


Risk Grade

Where does ZTS fit in the risk graph?


Risk Grade Scale

Consensus Recommendation

Analyst Info